Iryna Kuchuk
Ottawa, ON, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
ER + HER2- early-stage breast cancer: association of HER2 expression, tumor characteristics, and outcomes.
Journal: Breast cancer research and treatment
Published: June 11, 2024
The impact of germline BRCA pathogenic variants in locally advanced, triple negative breast cancer treated with platinum-based neoadjuvant chemotherapy.
Journal: Breast cancer research and treatment
Published: November 12, 2023
Clinical outcomes in estrogen receptor-positive early-stage breast cancer patients with Recurrence Score 26-30: observational real-world cohort study.
Journal: NPJ breast cancer
Published: November 23, 2022
Histomorphometric and microarchitectural analysis of bone in metastatic breast cancer patients.
Journal: Bone reports
Published: May 13, 2021
Taxane versus vinorelbine in combination with trastuzumab and pertuzumab for first-line treatment of metastatic HER2-positive breast cancer: a retrospective two-center study.
Journal: Breast cancer research and treatment
Published: January 15, 2021
Ethnicity, recurrence score distribution, and clinical outcomes in ER + HER2-negative breast cancer patients in Israel: A registry analysis.
Journal: The breast journal
Published: April 04, 2020
Evaluation of tolerability and efficacy of incorporating carboplatin in neoadjuvant anthracycline and taxane based therapy in a BRCA1 enriched triple-negative breast cancer cohort.
Journal: Breast (Edinburgh, Scotland)
Published: February 07, 2018
Symptom cluster of emotional distress, fatigue and cognitive difficulties among young and older breast cancer survivors: The mediating role of subjective stress.
Journal: Journal of geriatric oncology
Published: December 31, 2017
Estrogen, progesterone, and HER2/neu receptor discordance between primary and metastatic breast tumours-a review.
Journal: Cancer metastasis reviews
Published: July 14, 2016
Can the referring surgeon enhance accrual of breast cancer patients to medical and radiation oncology trials? The ENHANCE study.
Journal: Current oncology (Toronto, Ont.)
Published: June 23, 2016
A randomized, double-blind, phase II, exploratory trial evaluating the palliative benefit of either continuing pamidronate or switching to zoledronic acid in patients with high-risk bone metastases from breast cancer.
Journal: Breast cancer research and treatment
Published: September 16, 2015
Last Updated: 09/26/2026